Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Carcinogenesis

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/carcin/bgt099PMID 23524196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release

  2012cited by this paper
• Expression of P2X7 receptor increases in vivo tumor growth.

  2012cited by this paper
• P2X7 receptor antagonism in the treatment of cancers

  2011cited by this paper
• NaV1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolae

  2011cited by this paper
• P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor.

  2010cited by this paper
• C-terminal Calmodulin-binding Motif Differentially Controls Human and Rat P2X7 Receptor Current Facilitation*

  2010cited by this paper
• Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.

  2010cited by this paper
• Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions

  2010cited by this paper
• Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells.

  2010cited by this paper
• Targeting P2X7 receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes

  2010cited by this paper
• Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma

  2010cited by this paper
• Signaling at purinergic P2X receptors.

  2009cited by this paper
• Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model

  2009cited by this paper
• Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells*

  2009cited by this paper
• P2X7: a growth-promoting receptor—implications for cancer

  2009cited by this paper
• Facilitation of P2X7 Receptor Currents and Membrane Blebbing via Constitutive and Dynamic Calmodulin Binding

  2008cited by this paper
• Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

  2008cited by this paper
• Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1.

  2008cited by this paper
• Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?

  2008cited by this paper
• Functional genomics of calcium channels in human melanoma cells

  2007cited by this paper
• Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states

  2007cited by this paper
• Liaisons dangereuses: P2X(7) and the inflammasome.

  2007cited by this paper
• Cysteine cathepsins: multifunctional enzymes in cancer

  2006cited by this paper
• The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism.

  2006cited by this paper
• P2 receptors and cancer.

  2006cited by this paper
• Functional genomics of calcium channels in human melanoma cells.

  2006cited by this paper
• The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial Cancers

  2006cited by this paper
• Purinergic signalling

  2006cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth.

  2005cited by this paper
• Expression of the apoptotic calcium channel P2X7 in the glandular epithelium

  2005cited by this paper
• Early prostate cancer detected using expression of non‐functional cytolytic P2X7 receptors

  2004cited by this paper
• P2X7 receptor-mediated apoptosis of human cervical epithelial cells.

  2004cited by this paper
• Expression of P2X7 in human hematopoietic cell lines and leukemia patients.

  2004cited by this paper
• P2X7 receptor inhibition improves recovery after spinal cord injury

  2004cited by this paper
• Differentiation between Cancerous and Normal Hyperplastic Lobules in Breast Lesions

  2004cited by this paper
• P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Molecular physiology of P2X receptors.

  2002cited by this paper
• Cytolytic P2X purinoceptors

  1998cited by this paper
• Receptors for purines and pyrimidines.

  1998cited by this paper
• The Permeabilizing ATP Receptor, P2X7

  1997cited by this paper
• The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7)

  1996cited by this paper
• Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties.

  1991cited by this paper
• Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies.

  1988cited by this paper
• Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A.

  1972cited by this paper

• Emodin retards renal cyst progression in ADPKD by inhibiting cell proliferation and decreasing oxidative stress.

  2026cites this paper
• P2X7 receptor as a key player in pathological pain: insights into Neuropathic, inflammatory, and cancer pain

  2025cites this paper
• Unraveling the role of the P2X7 receptor in cancer radioresistance: Molecular insights and therapeutic implications.

  2025cites this paper
• Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compound.

  2024cites this paper
• Screening herbal and natural product libraries to aid discovery of novel allosteric modulators of human P2X7

  2024influential citation
• Progress on the mechanism of action of emodin against breast cancer cells

  2024cites this paper
• Role and Therapeutic Potential of P2X7 Receptor in Lung Cancer Progression.

  2024cites this paper
• Role of the P2X7 receptor in breast cancer progression

  2024cites this paper
• A Hybrid Approach Combining Shape-Based and Docking Methods to Identify Novel Potential P2X7 Antagonists from Natural Product Databases

  2024cites this paper
• The Himalayan rhubarb (Rheum australe D. Don.): an endangered medicinal herb with immense ethnobotanical ‘use-value’

  2024cites this paper
• Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.

  2024cites this paper
• Metabolomics analysis reveals the metabolite profiles of Rheum tanguticum grown under different altitudinal gradients

  2024cites this paper
• Role of P2X7 receptor in the progression and clinicopathological characteristics of gastric cancer

  2024cites this paper
• Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy

  2024cites this paper
• Research Progress and New Perspectives of Anticancer Effects of Emodin.

  2023cites this paper
• Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer

  2023cites this paper
• Tumour immune escape via P2X7 receptor signalling

  2023cites this paper
• Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation

  2023cites this paper
• Emodin reduces surgical wounding‐accelerated tumor growth and metastasis via macrophage suppression in a murine triple‐negative breast cancer model

  2023cites this paper
• The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk

  2023cites this paper
• Inflammasomes in breast cancer: the ignition spark of progression and resistance?

  2023cites this paper
• Animal Models for the Investigation of P2X7 Receptors

  2023cites this paper
• Identification of residues in the first transmembrane domain of the P2X7 that regulates receptor trafficking, sensitization, and dye uptake function

  2023cites this paper
• P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways

  2023cites this paper
• An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential

  2023cites this paper
• Purinergic signaling: Diverse effects and therapeutic potential in cancer

  2023cites this paper
• Emodin reduces tumor burden by diminishing M2-like macrophages in colorectal cancer.

  2022cites this paper
• miR-1306-3p directly activates P2X3 receptors in primary sensory neurons to induce visceral pain in rats

  2022cites this paper
• Emerging roles of the P2X7 receptor in cancer pain

  2022cites this paper
• Recent advances in the therapeutic potential of emodin for human health.

  2022cites this paper
• Research Progress in the Relationship Between P2X7R and Cervical Cancer

  2022cites this paper
• Administration of P2X7 Receptor Blockers in Oncological Experimental Models.

  2022cites this paper
• The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers

  2022cites this paper
• Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling

  2022cites this paper
• Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression

  2022cites this paper
• P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells

  2022cites this paper
• The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications

  2022cites this paper
• Synthesis and application of molecularly imprinted polymers for preferential removal of emodin and physcion from Polygonum multiflorum stem extract

  2022cites this paper
• Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis

  2021cites this paper
• P2X4 Receptors Mediate Ca2+ Release from Lysosomes in Response to Stimulation of P2X7 and H1 Histamine Receptors

  2021cites this paper
• Fatty acid synthesis and prostate cancer

  2021cites this paper
• To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question

  2021cites this paper
• Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin

  2021influential citation
• P2X7 receptor: a critical regulator and potential target for breast cancer

  2021cites this paper
• Natural Phytochemicals in Bladder Cancer Prevention and Therapy

  2021cites this paper
• Molecular encapsulation of berberine and ethidium bromide in anthraquinonecarboxamido-β-cyclodextrin conjugate: supramolecular association with DNA duplex and G-quadruplexes

  2021cites this paper
• Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment

  2021cites this paper
• Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer

  2021cites this paper
• How Cells Communicate with Each Other in the Tumor Microenvironment: Suggestions to Design Novel Therapeutic Strategies in Cancer Disease

  2021cites this paper
• Safety of natural anthraquinone emodin: an assessment in mice

  2021cites this paper
• Plant Science Today

  2020cites this paper
• Compounds of traditional Chinese medicine and neuropathic pain.

  2020cites this paper
• Purinergic Signaling Involvement in Thymosin β4-mediated Corneal Epithelial Cell Migration

  2020cites this paper
• To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?

  2020cites this paper
• P2X7 in Cancer: From Molecular Mechanisms to Therapeutics

  2020cites this paper
• P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer Treatment

  2020cites this paper
• Plant natural products as source of new P2 receptors ligands.

  2020cites this paper
• The P2X7 purinergic receptor: a potential therapeutic target for lung cancer

  2020cites this paper
• Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor

  2020cites this paper
• Activation of P2×7 Receptor Promotes the Invasion and Migration of Colon Cancer Cells via the STAT3 Signaling

  2020cites this paper
• Investigation and identification of the multiple components of Rheum officinale Baill. Using ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight tandem mass spectrometry and data mining strategy.

  2020cites this paper
• P2X7 blockade inhibits the growth of breast cancer in 4T1 breast cancer-bearing mice by NLRP3/caspase 1 pathway

  2020cites this paper
• Calcium signaling: breast cancer’s approach to manipulation of cellular circuitry

  2020cites this paper
• Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT‐116

  2020cites this paper
• Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2.

  2019cites this paper
• Adenosine Triphosphate Release and P2 Receptor Signaling in Piezo1 Channel-Dependent Mechanoregulation

  2019cites this paper
• The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway

  2019cites this paper
• Highlight Article: P2RX7 functions as a putative biomarker of gastric cancer and contributes to worse prognosis

  2019cites this paper
• Elucidation of biological properties of some commercial anthraquinones: Mutagenic / antimutagenic and antimicrobial activity approaches

  2019cites this paper
• Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics

  2019cites this paper
• Role of the P2X7 receptor in tumor-associated inflammation.

  2019cites this paper
• Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a

  2019cites this paper
• Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell

  2019cites this paper
• Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor

  2018cites this paper
• Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells

  2018cites this paper
• Raddeanin a Suppresses Glioblastoma Growth by Inducing ROS Generation and Subsequent JNK Activation to Promote Cell Apoptosis

  2018cites this paper
• The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer

  2018cites this paper
• The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

  2018cites this paper
• Extracellular ATP and P2 purinergic signalling in the tumour microenvironment

  2018cites this paper
• Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15

  2018cites this paper
• Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators

  2018cites this paper
• Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP85-99) epitope: Towards selective immunosuppression.

  2018cites this paper
• Pharmacokinetics of Botanical Drugs and Plant Extracts.

  2017cites this paper
• P2X7 receptor antagonists: a patent review (2010–2015)

  2017cites this paper
• Emodin suppresses the nasopharyngeal carcinoma cells by targeting the chloride channels.

  2017cites this paper
• P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin

  2017cites this paper
• Investigation of Distinction Chemical Markers for Rhubarb Authentication Based on High-Performance Liquid Chromatography-Time-of-Flight Mass Spectrometry and Multivariate Statistical Analysis

  2017cites this paper
• Potential role of P2X7R in esophageal squamous cell carcinoma proliferation

  2017cites this paper
• Purinergic Signalling: Therapeutic Developments

  2017cites this paper
• ATP-induced Ca2+-signalling mechanisms in the regulation of mesenchymal stem cell migration

  2017cites this paper
• Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells

  2017cites this paper
• The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression

  2017cites this paper
• Profiling and analysis of multiple compounds in rhubarb decoction after processing by wine steaming using UHPLC-Q-TOF-MS coupled with multiple statistical strategies.

  2016cites this paper
• Pharmacological targeting of ion channels for cancer therapy: In vivo evidences.

  2016cites this paper
• Anthraquinones As Pharmacological Tools and Drugs

  2016cites this paper
• Triggering of Erythrocyte Cell Membrane Scrambling by Emodin

  2016cites this paper
• Global metabolite profiling and diagnostic ion filtering strategy by LC-QTOF MS for rapid identification of raw and processed pieces of Rheum palmatum L.

  2016cites this paper
• Emodin and Its Role in Chronic Diseases.

  2016cites this paper
• Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics

  2016cites this paper
• P2X7 Receptor as a Therapeutic Target.

  2016cites this paper